Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Etretinate. A clinician's view.

R K Landow1

  • 1University of Southern California School of Medicine, Los Angeles.

Dermatologic Clinics
|October 1, 1988
PubMed
Summary
This summary is machine-generated.

Etretinate can treat resistant skin conditions and tumors but rarely cures them. Due to toxicity and accumulating side effects, long-term etretinate therapy is often not feasible.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The interferons. A clinician's view.

Dermatologic clinics·1988
Same author

New drugs for dermatologic diseases.

Dermatologic clinics·1988
Same author

Differential diagnosis and treatment of pigmented skin lesions.

Comprehensive therapy·1988
Same author

Naftifine cream 1% versus econazole cream 1% in the treatment of tinea cruris and tinea corporis.

Journal of the American Academy of Dermatology·1988
Same author

Dermatology-important advances in clinical medicine: diagnosis of primary melanoma.

The Western journal of medicine·1983
Same author

Dermatology-important advances in clinical medicine: surgical treatment of primary malignant melanoma.

The Western journal of medicine·1983
Same journal

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026
Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026
Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026
Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026
Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026
Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026
See all related articles

Area of Science:

  • Dermatology
  • Oncology

Background:

  • Etretinate is a retinoid used for treating dermatoses and tumors.
  • Its efficacy is often limited to suppression rather than cure.

Purpose of the Study:

  • To evaluate the therapeutic potential and limitations of etretinate.
  • To highlight the challenges associated with its long-term use.

Main Methods:

  • Clinical observations on patient response to etretinate therapy.
  • Assessment of adverse reactions and treatment duration.

Main Results:

  • Etretinate suppresses conditions but rarely provides a cure.
  • High toxicity limits long-term patient adherence, with many seeking alternatives within 3-6 months.

Related Experiment Videos

  • Adverse reactions appear to accumulate with prolonged administration.

    • Conclusions:

    • Etretinate offers a treatment option for resistant conditions but has significant limitations.
    • Patient tolerance is a major concern due to toxicity and side effects.
    • Alternative treatments, such as isotretinoin, should be considered before initiating etretinate, especially for young women.